Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with ≥5 Positive Ipsilateral Lymph Nodes
Int J Radiat Oncol Biol Phys
.
2022 Sep 1;114(1):10-11.
doi: 10.1016/j.ijrobp.2022.04.018.
Authors
Bailey Nelson
1
,
Vinita Takiar
1
Affiliation
1
Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.
PMID:
35964623
DOI:
10.1016/j.ijrobp.2022.04.018
No abstract available
Publication types
Editorial
MeSH terms
Combined Modality Therapy
Humans
Lymph Nodes / pathology
Oropharyngeal Neoplasms* / pathology
Oropharyngeal Neoplasms* / therapy
Papillomaviridae
Grants and funding
IK2 BX004360/BX/BLRD VA/United States